ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INDV Indivior Plc

1,441.00
-22.00 (-1.50%)
Last Updated: 13:10:18
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Indivior Plc LSE:INDV London Ordinary Share GB00BN4HT335 ORD USD0.50
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -22.00 -1.50% 1,441.00 1,440.00 1,443.00 1,461.00 1,425.00 1,450.00 112,102 13:10:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 1.09B 2M 0.0148 974.32 1.95B
Indivior Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker INDV. The last closing price for Indivior was 1,463p. Over the last year, Indivior shares have traded in a share price range of 1,128.00p to 1,927.00p.

Indivior currently has 135,272,708 shares in issue. The market capitalisation of Indivior is £1.95 billion. Indivior has a price to earnings ratio (PE ratio) of 974.32.

Indivior Share Discussion Threads

Showing 826 to 848 of 4425 messages
Chat Pages: Latest  45  44  43  42  41  40  39  38  37  36  35  34  Older
DateSubjectAuthorDiscuss
06/4/2019
09:34
NOT TOTALLY IGNORED

ENJOY YOUR WEEKEND AND LETS EXPECT AN EXCITING UPWARD NEXT WEEK

grupo guitarlumber
06/4/2019
09:30
(INDV)
Delayed London Stock Exchange - 04/05 04:35:20 pm
99.16 GBp +1.29%

grupo guitarlumber
06/4/2019
09:11
excellent news yesterday on the efficacy of Sublocade went unnoticed by the market. That us the company being valued at less than net cash in a strong market leaves me scratching my head
dealy
28/3/2019
20:50
I agree. The dust will settle though and these will recover again.
rafieh
28/3/2019
17:50
The overhang in this sub sector is as a result of the New York State's legal action against a number of companies, including J and J and Teva , addressing the opiod market. All in this area have had their share prices hit.
gregmorg
28/3/2019
12:59
Keep it hush otherwise they make sure it goes back down lol
pally12
28/3/2019
08:45
Buyers are coming back. Repeat journey to 110+ has started.
rafieh
27/3/2019
13:24
a lot of my small caps have fallen 20% on no news over the last few days
dealy
27/3/2019
13:07
Should bounce from these levels, or thereabouts.
rafieh
27/3/2019
12:43
92.93 GBp -9.60%
grupo guitarlumber
27/3/2019
12:41
03/27/19 Academy of Managed Care Pharmacy Meeting
grupo guitarlumber
27/3/2019
12:24
Nasty fall on no news unless a leak on Q1 revenues.
sparky333
27/3/2019
12:03
Looks ripe for a bid especially with the cash.
sparky333
27/3/2019
11:33
Looking interesting at this level
sparky333
27/3/2019
11:33
What's happening here? This usually bounces before now.
upsondowns
26/3/2019
15:08
Have you taken into account the 438M USD provision which the Annual Report says may not be enough?
ewanwhose
26/3/2019
10:21
Time to sell lol
pally12
26/3/2019
09:23
Something fishy

and or Friday 29 March 2019 4 witches approaches


cheers

grupo guitarlumber
26/3/2019
08:56
03/27/19 Academy of Managed Care Pharmacy Meeting
grupo guitarlumber
26/3/2019
08:49
This is old news. Should not affect the price today. The drop today is part of the usual fluctuations we have seen over the last 3-4 months.
rafieh
26/3/2019
08:31
Dr. Reddy’s Wants Indivior to Pay $70 Million for Opioid Delay
By Ari Altstedter
11 mars 2019 à 10:59 UTC+1 Updated on 11 mars 2019 à 22:30 UTC+1

Indivior blocked Dr Reddy’s generic version of Suboxone Film
U.S. Supreme Court had lifted the injunction last month



Dr. Reddy’s Laboratories Ltd. is seeking more than $70 million from Indivior Plc as compensation for lost U.S. sales of its generic version of a leading opioid addiction treatment that was delayed in a patent dispute with the U.K.-based drugmaker.

Indivior had managed to block Dr. Reddy’s generic version of Suboxone Film through a court injunction in July, despite the Indian company receiving regulatory approval earlier to sell the market-leading product for treating opioid dependence. Last month, the U.S. Supreme Court refused to uphold that injunction, allowing Dr. Reddy’s to resume sales of the drug.

grupo guitarlumber
26/3/2019
08:24
company is currently valued at net cash. no value assigned to the products or IP. insanely low valuation
dealy
26/3/2019
08:17
Time to top up, or open a short term trade.
rafieh
Chat Pages: Latest  45  44  43  42  41  40  39  38  37  36  35  34  Older

Your Recent History

Delayed Upgrade Clock